Search
for
Sort by
Research 271–300 of 561
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Meta-Analysis of Gene Expression Reveals the Core Transcriptomic Profile of Lesional Scalp in Alopecia Areata
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Consider Cultural Practices and Barriers to Care When Treating Alopecia Areata
- Th1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Journal of Population Therapeutics and Clinical Pharmacology
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- Modern Management Approaches for Alopecia Areata
- Treatment of frontal fibrosing alopecia: literature review 2020-2025
- New treatment modalities of alopecia areata
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- What’s new in the treatment of hair loss?
- Alopecia areata, actualización clínica y terapéutica
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
- Alopecia areata
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Dermatologia Capilar: Fisiologia do Folículo Piloso e Principais Afecções
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- CO149 Does the EQ-5D Measure the Full Impact of Alopecia Areata on Patients' Health Related Quality of Life?
- Survey of pediatric dermatologist views on treatment for alopecia areata
- Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., “Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata”
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Nitric oxide-releasing nanocarriers integrated with ginsenoside compound K in dissolvable microneedles for androgenetic alopecia
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Oral Tofacitinib in Refractory Pediatric Alopecia Areata
- Successful treatment of severe diffuse alopecia areata with abrocitinib